Bios Life C Clinical Studies

Unicity International is dedicated
to the continual development of the highest quality nutritional
and personal care products in the world.

Our comprehensive approach to product development guarantees
that our formulas are effective, complete, balanced, and safe.
All of our products are based on
solid scientific research with
ingredients that have published
peer-reviewed clinical studies backing their efficacy.

Unicity offers over 120 health and wellness products
that meet our exacting standards.
Our many unique and patented product formulations
have been developed through nutritional, clinical,
and medical research
to enhance your overall health and well-being.

The flagship of Unicity’s product line is Bios Life
—a product destined to revolutionize the preventive care industry.

Product

Bios Life reduces your risk for cardiovascular disease by optimizing your cholesterol and other lipid parameters. Bios Life balances the blood sugar levels, and aids in weight management. Bios Life promotes natural nutrient absorption and stimulates the immune system.

Who should use this product?

Bios Life is a true total health product, so everyone will benefit from this product. People that have a specific need for the product are:

— persons with elevated risk for heart disease due to life style
— persons with elevated risk for heart disease due to family history
— persons with diabetes, both type 1 and 2
— persons that want to manage their weight in a natural way

Unique Selling Points

Bios Life contains
a patented mixture of 5 very soluble fibers.
To make the fiber matrix form extra fast 
in your digestive tract,
the product contains calcium carbonate
that upon reaction with the acid
in the stomach forms carbon dioxide.
This bubbling enhances the fiber effect on cholesterol.
Apart from fiber,
Bios Life contains
three other cholesterol optimizing ingredients:
phytosterols,
policosanol, and
Chrysanthemum morifolium.

Bios Life further contains
a patented form of chromium (ChromeMate)
that sensitises insulin,
further lowering average glucose levels in the blood.

Bios Life has been studied
in a number of state-of-the-art clinical studies,
proving that it is effective in lowering LDL cholesterol,
increasing HDL cholesterol,
lowering triglycerides, and average glucose levels.

Clinical Studies

Cleveland Clinic Trial by Dr. Dennis SprecherPublished in Sprecher DL, Pearce GL (2002) Fiber-multivitamin combination therapy: a beneficial influence on lowdensity lipoprotein and homocysteine Metabolism 51, 1166-70.

Published in Freed S, Joffe D (2000) The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes Diabetes in Control 12-8.

Diabetes in Control Study #2 by Steven Freed and David JoffePublished in Freed S, Joffe D (2004) The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes II Diabetes in Control 212, 17, and Verdegem P, Freed S, Joffe D (2005) The clinical impact of fiber supplementation for the reduction of postprandial blood blucose and reduction of complications from type-2 diabetes Diabetes 54, A425.

Presented by Verdegem P, Freed S, Joffe D. The Clinical Impact of Fiber Supplementation on Cardio-Vascular Risk Parameters in type-2 Diabetes in 6th International Conference on Atherosclerosis, Thrombosis and Vascular Biology. 2005. Washinton, DC, USA. The American Heart Association sent out a press release on the study results.

Presented by Verdegem P, Freed S, Joffe D. The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Type-2 Diabetes. in 65th Scientific Session American Diabetes Association. 2005. San Diego, CA, USA.

Philippines Trial by Dr. YumulPresented by Balajadia E, Valerio A, Yumul N. Beneficial effects of Bios Life 2 (Dietary Fiber Supplement) in patients with dyslipidemia. in 34th Annual Convention of the Philippine College of Physicians. 2004.

Utah Trial by Dr. Peter J.E. VerdegemAs published by Verdegem P (2007) Viscous soluble fiber combined with phytosterols and policosanol reduces LDL-c and increases HDL-c in hypercholesterolemia Current Topics in Neutraceutical Research.

Utah Trial #2 by Dr. Peter J.E. VerdegemAs presented by Verdegem P, Duenas V, Duenas J, Burke E. LDL- and HLD-cholesterol optimization using phytonutrient combination therapy: first line intervention and adjunct therapy to statins in 1st Asian Preventive Cardiology & Cardiac Rehabilitation Conference. 2006. Hong Kong.

Presented at the 7th International Congress on Coronary Artery Disease, 2007, Venice, Italy.

Pacific Rim Trial by Dr. Vincent DuenasPublished in Duenas V, Duenas J, Burke E, Verdegem P (2006) A new fiber drink can serve as an adjunct therapy to statin medication in mild hypercholesterolemia Arterioscler Thromb Vasc Biol 26, e53-e107.

Presented by Duenas V, Duenas J, Burke E, Verdegem P. A new fiber drink can serve as an adjunct therapy to statin medication in mild hypercholesterolemia. in 7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2006. Denver.

Texas Trial by Dr. Isabel MartinezPresented by Martinez I, Horne B, Verdegem P. Lipid and glucose optimization using phytonutrient combination therapy in diabetes. In 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2007. Chicago.